Alimera Sciences Inc (ALIM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Alimera Sciences Inc (ALIM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7072
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabetic macular edema (DME) in patients who have been previously treated with corticosteroids and did not show any clinically significant increase in intraocular pressure (IOP). Iluvien is also prescribed for treatment of early-and late-stage diseases such as wet and dry age-related macular degeneration (AMD) and retinal vein occlusion. The company distributes its products in France, Austria, Portugal, the Czech Republic, Denmark, Finland, Germany, Spain, the UK and others. Alimera is headquartered in Alpharetta, Georgia, the US.

Alimera Sciences Inc (ALIM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alimera Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alimera Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Alimera Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alimera Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Alimera Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Alimera Sciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Alimera Sciences Enters into Licensing Agreement with pSivida 10
Equity Offering 11
Alimera Sciences Plans to Raise up to USD100 Million in Public Offering of Securities 11
Alimera Sciences Completes Private Placement Of Units For US$40 Million 12
Acquisition 14
Alimera Sciences Mulls for Sale 14
Alimera Sciences Inc – Key Competitors 15
Alimera Sciences Inc – Key Employees 16
Alimera Sciences Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Jul 31, 2018: Alimera Sciences Reports Second Quarter 2018 Results 18
May 02, 2018: Alimera Sciences Reports First Quarter 2018 Results 20
Feb 28, 2018: Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results 22
Nov 01, 2017: Alimera Sciences Reports Third Quarter 2017 Financial Results 24
Aug 02, 2017: Alimera Sciences Reports Second Quarter 2017 Financial Results 26
May 08, 2017: Alimera Sciences Reports First Quarter 2017 Financial Results 28
Mar 01, 2017: Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results 30
Corporate Communications 32
Jun 21, 2018: Alimera Sciences Names Mary T. Szela As Board Director 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Alimera Sciences Inc, Medical Equipment, Key Facts, 2017 2
Alimera Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Alimera Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alimera Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Alimera Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alimera Sciences Inc, Deals By Market, 2012 to YTD 2018 8
Alimera Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Alimera Sciences Enters into Licensing Agreement with pSivida 10
Alimera Sciences Plans to Raise up to USD100 Million in Public Offering of Securities 11
Alimera Sciences Completes Private Placement Of Units For US$40 Million 12
Alimera Sciences Mulls for Sale 14
Alimera Sciences Inc, Key Competitors 15
Alimera Sciences Inc, Key Employees 16
Alimera Sciences Inc, Subsidiaries 17

List of Figures
Alimera Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Alimera Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Alimera Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Alimera Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Alimera Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alimera Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Alimera Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alimera Sciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Alimera Sciences Inc (ALIM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MAPFRE RE, Compania de Reaseguros S.A.:企業の戦略・SWOT・財務情報
    MAPFRE RE, Compania de Reaseguros S.A. - Strategy, SWOT and Corporate Finance Report Summary MAPFRE RE, Compania de Reaseguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Maquet Holding BV & Co KG:医療機器:M&Aディール及び事業提携情報
    Summary Maquet Holding BV & Co KG (Maquet), a subsidiary of Getinge AB, designs, develops and sells medical systems. The company’s major products include anesthesia delivery systems, surgical assist systems, fixed equipment, mobile equipment, operation room lights and ceiling supply units, vascular …
  • Mallinckrodt LLC:医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt LLC (Mallinckrodt), formerly Therakos Inc, a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis. The company provides Therakos Cellex Photopheresis system, which is indicated for use in ultraviolet-A irradiation i …
  • Dick’s Sporting Goods Inc:戦略・SWOT・企業財務分析
    Dick’s Sporting Goods Inc - Strategy, SWOT and Corporate Finance Report Summary Dick’s Sporting Goods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PT. Bank Rakyat Indonesia (Persero) Tbk.:企業の戦略・SWOT・財務情報
    PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Accenture plc:企業の戦略・SWOT・財務情報
    Accenture plc - Strategy, SWOT and Corporate Finance Report Summary Accenture plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Gulfsands Petroleum Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Gulfsands Petroleum Plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • Acorda Therapeutics Inc (ACOR):企業の財務・戦略的SWOT分析
    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • University of Texas Health Science Center at San Antonio-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • Vaccinex Inc (VCNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • TriMedx LLC:企業の戦略的SWOT分析
    TriMedx LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Halliburton Co (HAL)-石油・ガス分野:企業M&A・提携分析
    Summary Halliburton Company (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completio …
  • Major Drilling Group International Inc (MDI):企業の財務・戦略的SWOT分析
    Major Drilling Group International Inc (MDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Booz Allen Hamilton Holding Corporation:企業の戦略・SWOT・財務情報
    Booz Allen Hamilton Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Booz Allen Hamilton Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Loral Space & Communications Inc. (LORL):企業の財務・戦略的SWOT分析
    Loral Space & Communications Inc. (LORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hachsharat Hayishuv Hotels Ltd.:企業の戦略・SWOT・財務分析
    Hachsharat Hayishuv Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hachsharat Hayishuv Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cipher Pharmaceuticals Inc (CPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Cipher Pharmaceuticals Inc (Cipher) is a pharmaceutical company that develops skin care solutions. The company provides products such as actikerall, a topical solution indicated for the treatment of hyperkeratotic actinic keratosis; beteflam, a topical patch used for the treatment of mild to …
  • MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …
  • Shree Cement Limited:企業の戦略・SWOT・財務情報
    Shree Cement Limited - Strategy, SWOT and Corporate Finance Report Summary Shree Cement Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mediolanum farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a developer and supplier of pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas, which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, vascular area and cardiometabolics. It …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆